SHANGHAI MICROPORT EP MEDTECH CO., LTD. Financials Shanghai MicroPort EP MedTech Co., Ltd.
Equities
688351
CNE100005PG9
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.22 CNY | -0.83% |
|
+2.74% | +2.22% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 12,457 | 12,071 | 12,339 | - | - |
| Enterprise Value (EV) 1 | 12,457 | 11,814 | 11,700 | 11,613 | 12,339 |
| P/E ratio | 3,781 x | 2,120 x | 370 x | 178 x | 92 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 47.9 x | 36.7 x | 26.3 x | 18.7 x | 13.4 x |
| EV / Revenue | 47.9 x | 35.9 x | 25 x | 17.6 x | 13.4 x |
| EV / EBITDA | 707 x | 376 x | 225 x | 118 x | 70.6 x |
| EV / FCF | -302 x | -148 x | -355 x | 622 x | 194 x |
| FCF Yield | -0.33% | -0.68% | -0.28% | 0.16% | 0.51% |
| Price to Book | 7.43 x | 7.16 x | 7.17 x | 6.88 x | 6.4 x |
| Nbr of stocks (in thousands) | 470,600 | 470,600 | 470,600 | - | - |
| Reference price 2 | 26.47 | 25.65 | 26.22 | 26.22 | 26.22 |
| Announcement Date | 2/17/23 | 2/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 260.3 | 329.2 | 468.8 | 660.5 | 922.4 |
| EBITDA 1 | - | 17.62 | 31.38 | 52.02 | 98.65 | 174.8 |
| EBIT 1 | - | 3.026 | 7.646 | 37.04 | 82.99 | 158.4 |
| Operating Margin | - | 1.16% | 2.32% | 7.9% | 12.56% | 17.18% |
| Earnings before Tax (EBT) 1 | - | 2.972 | 5.61 | 36.44 | 80.79 | 156.4 |
| Net income 1 | -11.97 | 2.972 | 5.689 | 33.47 | 70.19 | 133 |
| Net margin | - | 1.14% | 1.73% | 7.14% | 10.63% | 14.42% |
| EPS 2 | -0.0299 | 0.007000 | 0.0121 | 0.0709 | 0.1472 | 0.2850 |
| Free Cash Flow 1 | - | -41.31 | -79.9 | -33 | 18.67 | 63.5 |
| FCF margin | - | -15.87% | -24.27% | -7.04% | 2.83% | 6.88% |
| FCF Conversion (EBITDA) | - | - | - | - | 18.92% | 36.32% |
| FCF Conversion (Net income) | - | - | - | - | 26.6% | 47.74% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 8/10/22 | 2/17/23 | 2/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: |
|---|
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | - | 256 | 639 | 726 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -41.3 | -79.9 | -33 | 18.7 | 63.5 |
| ROE (net income / shareholders' equity) | - | 0.31% | 0.34% | 1.95% | 3.97% | 7.04% |
| ROA (Net income/ Total Assets) | - | 0.24% | 0.31% | 1.57% | 3.18% | 4.5% |
| Assets 1 | - | 1,229 | 1,808 | 2,127 | 2,210 | 2,956 |
| Book Value Per Share 2 | - | 3.560 | 3.580 | 3.660 | 3.810 | 4.100 |
| Cash Flow per Share 2 | - | -0.0200 | -0.0800 | 0.1300 | 0.1600 | 0.3300 |
| Capex 1 | - | 31.9 | 41.9 | 97.7 | 81.1 | 104 |
| Capex / Sales | - | 12.26% | 12.74% | 20.84% | 12.27% | 11.27% |
| Announcement Date | 8/10/22 | 2/17/23 | 2/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.22
CNY
Average target price
28.11
CNY
Spread / Average Target
+7.19%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.22% | 1.72B | |
| -15.43% | 18.51B | |
| -40.81% | 2.85B | |
| +19.34% | 1.95B | |
| +28.27% | 1.26B | |
| -9.56% | 1.02B | |
| -16.29% | 950M | |
| +0.07% | 777M | |
| -22.49% | 643M | |
| +11.79% | 518M |
- Stock Market
- Equities
- 688351 Stock
- Financials Shanghai MicroPort EP MedTech Co., Ltd.